Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -1,920 | -1,620 | 210 |
| Depreciation Amortization | N/A | N/A | 0 | 1 | 570 |
| Other Working Capital | N/A | N/A | -130 | 600 | -1,020 |
| Other Operating Activity | 0 | 0 | 710 | 179 | 120 |
| Operating Cash Flow | $N/A | $N/A | $-1,340 | $-840 | $-120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -20 | -70 | -1,000 |
| Net Acquisitions | N/A | N/A | 0 | -280 | 0 |
| Other Investing Activity | 0 | 0 | 160 | 0 | 30 |
| Investing Cash Flow | $N/A | $N/A | $140 | $-350 | $-970 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 1,200 | 1,140 | 710 |
| Financing Cash Flow | $N/A | $N/A | $1,200 | $1,140 | $710 |
| Exchange Rate Effect | N/A | N/A | 0 | 0 | 40 |
| Beginning Cash Position | N/A | N/A | 1 | 40 | 690 |
| End Cash Position | N/A | N/A | 4 | 1 | 360 |
| Net Cash Flow | $N/A | $N/A | $3 | $-40 | $-330 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -1,340 | -840 | -120 |
| Free Cash Flow | 0 | 0 | -1,340 | -840 | -120 |